Fondazione IRCCS Istituto Nazionale dei Tumori — Milan, Milano

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Milan →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Fondazione IRCCS Istituto Nazionale dei Tumori, compiled from the ClinicalTrials.gov public registry.

586

Registered studies

308

Active

181

Recruiting now

195

Completed

41

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Breast Neoplasms · Gastroesophageal Junction Adenocarcinoma · Recurrent or Metastatic Solid Tumors

Recently updated registry entries

NCT06393374 — Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… (Recruiting)
NCT07216703 — A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT04145349 — CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With… (Completed)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.